strong belief is the TH and suspension was done BEFORE any testing / analysis started. This is to limit the risk of results getting out and preventing any leak from impacting the share price or any other commercials.
I think we have two possibilities: 1. Doing analysis of the 3PL - and shutting down trading for the entire test and reporting period to prevent leakage. Clearly falls in the definition of a technical update. 2. Negotiating a licencing agreement which in theory could fall under a "technical update" as the terms of the agreement would likely be based on performance characteristics of the chip. Analysis would be required to finalise that type of commercial agreement and they would not need to say "trading halt pending finalisation of a commercial agreement". Signing a contract is not a reason to stop trading shares, but the technical update is a reason to stop.
This is only by excluding other scenarios as they have not stated any of the other "reasons" for the TH/suspension, which are typically - capital raising - corporate transaction - acquisition/disposal - merger/takeover - change in earnings guidance
Cannot go into trading halt / suspension to let another company do their due diligence.
If an offer came, even if intention of an offer came, it would have to be disclosed to market as a separate reason for the suspension or when continuing the suspension.
